Summary: A gene situated on chromosome 2 may increase the risk of fainting. Women, the study reports, have three times increased risk of fainting disorder.
Source: University of Copenhagen
Fainting is not solely caused by external factors. Your genes also play a part. This has recently been documented by a research team from the University of Copenhagen, Statens Serum Institut and Rigshospitalet. Based on data from more than 400,000 individuals they have identified the first gene that predisposes to fainting.
Heat, dehydration and anxiety can cause people to faint which potentially can be fatal if it is happening while driving or cycling. Now researchers from the University of Copenhagen, Statens Serum Institut and Rigshospitalet have come closer to explaining the phenomenon. They are the first to identify a gene associated with an increased risk of fainting, also called syncope.
The new research results have been published in the scientific journal Cardiovascular Research. The researchers have analysed data from the UK Biobank containing information on approximately 400,000 Britons. Out of the 400,000, 9,163 Britons had been in contact with the healthcare system due to fainting. In order to identify the genetic variants associated with fainting, the researchers systematically analysed millions of genetic variants in the participants’ genomes.
‘We have learned that a part of chromosome 2 increases the risk of fainting. This means that there is a genetic risk variant that predisposes to fainting. In addition, we are the first to show that fainting is genetically determined by linking an increased risk of fainting with an exact position in the genome,’ says Associate Professor Morten Salling Olesen from the Department of Biomedical Sciences, University of Copenhagen and the Laboratory for Molecular Cardiology, Rigshospitalet.
All of us have 23 chromosome pairs – or a total of 46 chromosomes in each cell. The genetic variant identified by the researchers is situated on chromosome 2. A person can have one, two or no risk variants on chromosome 2. Statistical calculations show that if the risk variant is found on both versions of chromosome 2, the person in question has a 30 percent higher risk of fainting compared to persons with none of the two variants.
Subsequent analyses have shown that the risk variant for syncope determines the extent to which a particular gene on chromosome 2 is expressed. The researchers believe that this misregulation of the gene is probably what increases the risk of fainting.
Young Women Faint more than Men
The researchers have also analysed data from a Danish cohort of 54,656 individuals called iPSYCH from Statens Serum Institut. The result confirmed their previous findings. Among the participants who had experienced fainting the researchers found the same genetic risk variant as in the British cohort. They discovered that women under the age of 35 faint approximately twice as often as men under the age of 35. The cause hereof is still unknown.
‘In the study we show that if you are a woman and you carry the risk variant on both chromosomes on chromosome pair number 2, you have approximately three times increased risk of fainting compared with men not carrying the risk variant. Your gender and a single genetic variant in your genome reveal a substantial part of your risk of fainting,’ says Morten Salling Olesen.
The common belief is that fainting is caused by a shortage of blood and oxygen to the brain, which results in short-term, total loss of consciousness. There are various types of syncope, the most frequent being vasovagal syncope. Here a reflex – e.g. triggered by the sight of blood – causes significant lowered blood pressure conditioned by a slow heart rate and a dilation of the blood vessels leading to reduced flow of blood to the brain and fainting.
Between 20 and 30 percent of the population is believed to faint at least once in their lifetime. The gene identified by the researchers to associate with fainting or syncope is called ZNF804A. They still do not know precisely which type of syncope the gene predisposes to.
‘This gene probably affects some of the reflexes that determine whether you faint or not. The question is whether the hereditary component is the same for all types of syncope. We believe that the gene we have identified predisposes to vasovagal syncope, which is the most common type of syncope. But we still do not know. First we need to study the gene in detail,’ says Morten Salling Olesen.
Source:
University of Copenhagen
Media Contacts:
Cecilie Krabbe – University of Copenhagen
Image Source:
The image is in the public domain.
Original Research: Open access
“Genome-wide association study identifies locus at chromosome 2q32.1 associated with syncope and collapse “. Morten Salling Olesen et al.
Cardiovascular Research. doi:10.1093/cvr/cvz106
Abstract
Genome-wide association study identifies locus at chromosome 2q32.1 associated with syncope and collapse
Aims
Syncope is a common condition associated with frequent hospitalization or visits to the emergency department. Family aggregation and twin studies have shown that syncope has a heritable component. We investigated whether common genetic variants predispose to syncope and collapse.
Methods and results
We used genome-wide association data on syncope on 408 961 individuals with European ancestry from the UK Biobank study. In a replication study, we used the Integrative Psychiatric Research Consortium (iPSYCH) cohort (n = 86 189), to investigate the risk of incident syncope stratified by genotype carrier status. We report on a genome-wide significant locus located on chromosome 2q32.1 [odds ratio = 1.13, 95% confidence interval (CI) 1.10–1.17, P = 5.8 × 10−15], with lead single nucleotide polymorphism rs12465214 in proximity to the gene zinc finger protein 804a (ZNF804A). This association was also shown in the iPSYCH cohort, where homozygous carriers of the C allele conferred an increased hazard ratio (1.30, 95% CI 1.15–1.46, P = 1.68 × 10−5) of incident syncope. Quantitative polymerase chain reaction analysis showed ZNF804A to be expressed most abundantly in brain tissue.
Conclusion
We identified a genome-wide significant locus (rs12465214) associated with syncope and collapse. The association was replicated in an independent cohort. This is the first genome-wide association study to associate a locus with syncope and collapse.
